International Skin Imaging Collaboration-Designated Diagnoses (ISIC-DX): Consensus terminology for lesion diagnostic labeling.

Autor: Scope A; The Kittner Skin Cancer Screening & Research Institute, Sheba Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Liopyris K; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Dermatology-Venereology, University of Athens Medical School, Athens, Greece., Weber J; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Barnhill RL; Department of Translational Research, Institut Curie, and UFR de Médecine, Université de Paris, Paris, France., Braun RP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Curiel-Lewandrowski CN; Department of Dermatology, University of Arizona College of Medicine, and the University of Arizona Cancer Center Skin Cancer Institute, Tucson, Arizona, USA., Elder DE; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ferrara G; Anatomic Pathology and Cytopathology Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Grant-Kels JM; Department of Dermatology, UConn Health, Farmington, Connecticut, USA.; Department of Dermatology, University of Florida, Gainesville, Florida, USA., Jeunon T; Departments of Dermatology and Pathology, Hospital Federal de Bonsucesso, Rio de Janeiro, Brazil., Lallas A; First Department of Dermatology, Aristotle University, Thessaloniki, Greece., Lin JY; Department of Dermatology, Brigham and Women's Hospital and Melanoma Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Marghoob AA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Navarrete-Dechent C; Melanoma and Skin Cancer Unit and Department of Dermatology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Pellacani G; Department of Dermatology, University of Modena and Reggio Emilia, Modena and Dermatology Clinic, University of Rome, Rome, Italy., Soyer HP; The University of Queensland Diamantina Institute, University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia., Stratigos A; 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Thomas L; Dermatology Department, Hôpital Universitaire Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Kittler H; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Rotemberg V; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Halpern AC; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 May 11. Date of Electronic Publication: 2024 May 11.
DOI: 10.1111/jdv.20055
Abstrakt: Background: A common terminology for diagnosis is critically important for clinical communication, education, research and artificial intelligence. Prevailing lexicons are limited in fully representing skin neoplasms.
Objectives: To achieve expert consensus on diagnostic terms for skin neoplasms and their hierarchical mapping.
Methods: Diagnostic terms were extracted from textbooks, publications and extant diagnostic codes. Terms were hierarchically mapped to super-categories (e.g. 'benign') and cellular/tissue-differentiation categories (e.g. 'melanocytic'), and appended with pertinent-modifiers and synonyms. These terms were evaluated using a modified-Delphi consensus approach. Experts from the International-Skin-Imaging-Collaboration (ISIC) were surveyed on agreement with terms and their hierarchical mapping; they could suggest modifying, deleting or adding terms. Consensus threshold was >75% for the initial rounds and >50% for the final round.
Results: Eighteen experts completed all Delphi rounds. Of 379 terms, 356 (94%) reached consensus in round one. Eleven of 226 (5%) benign-category terms, 6/140 (4%) malignant-category terms and 6/13 (46%) indeterminate-category terms did not reach initial agreement. Following three rounds, final consensus consisted of 362 terms mapped to 3 super-categories and 41 cellular/tissue-differentiation categories.
Conclusions: We have created, agreed upon, and made public a taxonomy for skin neoplasms and their hierarchical mapping. Further study will be needed to evaluate the utility and completeness of the lexicon.
(© 2024 European Academy of Dermatology and Venereology.)
Databáze: MEDLINE